---
title: "AMLX stock clocks best day ever after positive trial data, launches $350M offering"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296273366.md"
description: "Amylyx Pharmaceuticals (AMLX) shares surged 64% to record highs after positive late-stage LUCIDITY trial data for avexitide, a treatment for post-bariatric hypoglycemia. The drug reduced serious hypoglycemic events by 55% with a clean safety profile. Following the news, Amylyx launched a $350 million public offering to fund commercialization efforts and R&D. Analysts from H.C. Wainwright, Stifel, and Citi raised price targets and maintained Buy ratings, citing de-risked approval prospects."
datetime: "2026-08-18T21:48:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296273366.md)
  - [en](https://longbridge.com/en/news/296273366.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296273366.md)
generator: "portal-rs"
---

# AMLX stock clocks best day ever after positive trial data, launches $350M offering

・AMLX’s Tuesday rally followed positive topline data from the late-stage LUCIDITY study of avexitide, a once-daily injection for post-bariatric hypoglycemia. ・H.C. Wainwright raised its price target on Amylyx to $55 from $34 and kept a Buy rating following the trial data unveiling. ・Stifel called the clinical data a “best-case scenario” and “clear ...

### Related Stocks

- [AMLX.US](https://longbridge.com/en/quote/AMLX.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)

## Related News & Research

- [AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial](https://longbridge.com/en/news/296265581.md)
- [Amylyx drug cuts low blood sugar episodes in bariatric surgery patients in key trial](https://longbridge.com/en/news/296217967.md)
- [BUZZ-Amylyx dips after increased $500 mln stock sale to fund blood sugar drug](https://longbridge.com/en/news/296483560.md)
- [BUZZ-Amylyx Pharma starts $350 mln equity offering to fund blood sugar drug](https://longbridge.com/en/news/296266391.md)
- [Amylyx to release Phase 3 LUCIDITY trial topline results for avexitide in post-bariatric hypoglycemia Aug. 18, 2026](https://longbridge.com/en/news/296140552.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**